[1] |
STEVENSON G W, HOANG H, SCHWARTZ K J, et al. Emergence of porcine epidemic diarrhea virus in the United States:clinical signs, lesions, and viral genomic sequences[J]. J Vet Diagn Invest, 2013, 25(5):649-654.
|
[2] |
LIN C M, SAIF L J, MARTHALER D, et al. Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains[J]. Virus Res, 2016, 226:20-39.
|
[3] |
WANG D, FANG L R, XIAO S B. Porcine epidemic diarrhea in China[J]. Virus Res, 2016, 226:7-13.
|
[4] |
SEKHON S S, NGUYEN P L, AHN J Y, et al. Porcine epidemic diarrhea (PED) infection, diagnosis and vaccination:A mini review[J]. Toxicol Environ Health Sci, 2016,8(5):277-289.
|
[5] |
SONG D, PARK B. Porcine epidemic diarrhoea virus:a comprehensive review of molecular epidemiology, diagnosis, and vaccines[J]. Virus Genes, 2012, 44(2):167-175.
|
[6] |
LEE D K, PARK C K, KIM S H, et al. Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea[J]. Virus Res, 2010, 149(2):175-182.
|
[7] |
WICHT O, LI W, WILLEMS L, et al. Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture[J]. J Virol, 2014, 88(14):7952-7961.
|
[8] |
SUN D B, FENG L, SHI H Y, et al. Spike protein region (aa 636789) of porcine epidemic diarrhea virus is essential for induction of neutralizing antibodies[J]. Acta Virol, 2007, 51(3):149-156.
|
[9] |
SCHÖDEL F, PETERSON D, MILICH D. Hepatitis B virus core and e antigen:immune recognition and use as a vaccine carrier moiety[J]. Intervirology, 1996, 39(1-2):104-110.
|
[10] |
LEE P S, LEE K H. Escherichia coli-a model system that benefits from and contributes to the evolution of proteomics[J]. Biotechnol Bioeng, 2003,84(7):801-814.
|
[11] |
LIN L C, LEE T H, CHANG C H, et al. Predictors of clinical deterioration during hospitalization following acute ischemic stroke[J]. Eur Neurol, 2012, 67(3):186-192.
|
[12] |
SCHÖDEL F, PETERSON D, HUGHES J, et al. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety:I. presentation of foreign epitopes[J]. J Biotechnol, 1996, 44(1-3):91-96.
|
[13] |
LI W, LI H, LIU Y, et al. New variants of porcine epidemic diarrhea virus, China, 2011[J]. Emerg Infect Dis, 2012, 18(8):1350-1353.
|
[14] |
LI R F, QIAO S L, YANG Y Y, et al. Genome sequencing and analysis of a novel recombinant porcine epidemic diarrhea virus strain from Henan, China[J]. Virus Genes, 2016,52(1):91-98.
|
[15] |
SCHÖDEL F, KELLY S M, PETERSON D, et al. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines[J]. Dev Biol Stand, 1994, 82:151-158.
|
[16] |
GILLAM F, ZHANG J, ZHANG C. Hepatitis B core antigen based novel vaccine against porcine epidemic diarrhea virus[J]. J Virol Methods, 2018, 253:61-69.
|
[17] |
GILLAM F, ZHANG C. Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen[J]. Vaccine, 2018, 36(30):4507-4516.
|
[18] |
ROLDÃO A, MELLADO M C M, CASTILHO L R, et al. Virus-like particles in vaccine development[J]. Expert Rev Vaccines, 2010,9(10):1149-1176.
|
[19] |
MICHEL M L, TIOLLAIS P. Hepatitis B vaccines:protective efficacy and therapeutic potential[J]. Pathol Biol (Paris), 2010, 58(4):288-295.
|
[20] |
DENNER J. Hepatitis E virus (HEV)-The future[J]. Viruses, 2019, 11(3):251.
|
[21] |
WANG K, LU W, CHEN J, et al. PEDV ORF3 encodes an ion channel protein and regulates virus production[J]. FEBS Lett, 2012, 586(4):384-391.
|
[22] |
LIAO L B, YANG L, XU Y X, et al. Fusion-PCR generates attL recombination site adaptors and allows rapid one-step gateway (ROG) cloning[J]. Biochimie, 2020,174:69-73.
|